Machina Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Machina Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.45M	Sell	8,966 -688	-7%	-$305K	0.71%	38
2026 Q1	$4.31M	Buy	9,654 +4,590	+91%	+$2.14M	0.85%	17
2025 Q4	$2.3M	Sell	5,064 -6,103	-55%	-$2.63M	0.44%	76
2025 Q3	$4.37M	Buy	+11,167	New	+$4.67M	0.77%	30
2024 Q3	–	Sell	-2,117	Closed	-$992K	–	365
2024 Q2	$992K	Buy	2,117 +123	+6%	+$53.4K	0.45%	83
2024 Q1	$834K	Buy	+1,994	New	+$843K	0.44%	86
2023 Q4	–	Sell	-2,348	Closed	-$816K	–	361
2023 Q3	$816K	Buy	+2,348	New	+$821K	0.46%	83
2023 Q2	–	Sell	-900	Closed	-$284K	–	530
2023 Q1	$284K	Sell	900 -200	-18%	-$60K	0.25%	150
2022 Q4	$318K	Buy	+1,100	New	+$335K	0.59%	80
2020 Q1	–	Sell	-3,481	Closed	-$762K	–	294
2019 Q4	$762K	Sell	3,481 -1,251	-26%	-$253K	0.3%	133
2019 Q3	$802K	Sell	4,732 -743	-14%	-$131K	0.37%	98
2019 Q2	$1M	Sell	5,475 -9,172	-63%	-$1.6M	0.38%	90
2019 Q1	$2.69M	Buy	14,647 +13,780	+1,589%	+$2.55M	1.07%	9
2018 Q4	$144K	Buy	+867	New	+$150K	0.1%	225

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Machina Capital's VRTX Position: Q2 2026 in Review

Machina Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 7.1% in Q2 2026, selling an estimated $305K and leaving 8,966 shares worth $4.45M. The position accounts for 0.71% of the portfolio, ranked #38.

Machina Capital first reported a position in VRTX in Q4 2018 and has held it in 14 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Machina Capital held 8,966 shares of Vertex Pharmaceuticals worth $4.45M as of Q2 2026.
Machina Capital sold 688 Vertex Pharmaceuticals shares in Q2 2026, an estimated $305K.
Vertex Pharmaceuticals made up 0.71% of Machina Capital's portfolio in Q2 2026, its #38 holding.
Machina Capital first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.